Another meta-analysis in 2012 reported that AR CAG repeat polymorphism with ≥20 repeats might confer a protective effect among prostate cancer patients older than 45 years, but not all prostate cancer patients [37]. This evidence concerns the gene AR and Familial prostate cancer.